Associations of residents receiving concomitant use of CYP2D6-metabolized opioids with existing CYP2D6-inhibiting antidepressants (study group) vs. CYP2D6-neutral antidepressants (comparison group) with clinical worsening outcomes.
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Associations of residents receiving concomitant use of CYP2D6-metabolized opioids with existing CYP2D6-inhibiting antidepressants (study group) vs. CYP2D6-neutral antidepressants (comparison group) with clinical worsening outcomes.
创建时间：
2025-06-02
